Related Experiment Video
Updated: Dec 29, 2025
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
33.8K
Atrial Fibrillation in Hypertrophic Cardiomyopathy: Evidence-based Review About Mechanism, Complications and
Karuppiah Arunachalam1, Abhishek Maan2, Antony Chu1
1From the Division of Cardiology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island.
Critical Pathways in Cardiology
|February 4, 2020
Summary
Hypertrophic cardiomyopathy (HCM) patients have a high prevalence of atrial fibrillation, increasing mortality and stroke risk. Catheter ablation offers a feasible option to manage symptoms and reduce complications, with repeated procedures showing improved outcomes.
Area of Science:
- Cardiology
- Genetics
- Electrophysiology
Background:
- Hypertrophic cardiomyopathy (HCM) is a common genetic heart disease affecting 1 in 500 individuals.
- Atrial fibrillation (AF) affects 27.09% of HCM patients, increasing risks of death, stroke, and thromboembolism.
- Current medical management for AF in HCM yields variable results with high recurrence rates.
Purpose of the Study:
- To evaluate the effectiveness and safety of catheter ablation for managing atrial fibrillation in patients with hypertrophic cardiomyopathy.
- To assess the impact of AF on mortality and thromboembolic events in HCM patients.
- To explore the outcomes of repeated catheter ablation procedures in this patient population.
Main Methods:
- Review of medical literature on hypertrophic cardiomyopathy and atrial fibrillation management.
- Analysis of incidence and prevalence data for AF in HCM patients.
- Evaluation of treatment outcomes, including symptom burden, complications, and recurrence rates for medical and catheter ablation therapies.
Main Results:
- Atrial fibrillation has a significant prevalence (27.09%) and is associated with increased mortality and stroke risk in HCM.
- Catheter ablation demonstrates potential in reducing symptom burden and complications, despite moderate recurrence rates.
- Patients undergoing multiple catheter ablation procedures show enhanced success rates and better overall outcomes.
- The procedure is associated with low complication rates, indicating high feasibility.
Conclusions:
- Catheter ablation is a feasible and effective strategy for managing atrial fibrillation in hypertrophic cardiomyopathy patients.
- Repeated catheter ablation procedures may improve success rates and patient outcomes.
- Further research into advanced catheter ablation techniques is warranted to optimize AF management in HCM.
More Related Videos
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
307
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
307
01:29Cardiomyopathy V: Interprofessional Care
253
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
253
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
385
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
385
01:25Dysrhythmias VI: Management of Dysrhythmias
340
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
340
01:21Rheumatic Heart Disease III: Medical Management
232
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
232
01:30Cardiomyopathy II: Dilated Cardiomyopathy
380
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
380